Neurocrine Biosciences Inc. (NBIX)

NASDAQ

$141.57

$-0.93

(-0.65%)

Pre-Market

Neurocrine Biosciences Inc. (NBIX) Live Price Chart

Last updated: ⁦2026-10-12 13:23:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Neurocrine Biosciences Inc. (NBIX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $141.57, with a market capitalisation of $14.48B and a P/E ratio of 20.52. Over the past 52 weeks, its price has ranged from $122.14 to $186.12. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$14.48B
Open	$142.51
Day's High	$186.12
Day's Low	$1.94
Previous Close	$142.44
Volume	106.00
Average Volume	1.29M
P/E Ratio	20.52
52-Week High	$186.12
52-Week Low	$122.14
Dividend Yield	--
Earnings Date	--

Neurocrine Biosciences Inc. (NBIX) Pre-Market Stock Price

Neurocrine Biosciences Inc. (NBIX) is trading at $141.57 in pre-market trading as of 2026-10-12 13:21:00, down 0.61% ($0.87) from the previous close of $142.44

Pre-market trading shows how investors are pricing NBIX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Neurocrine Biosciences Inc. (NBIX) 7-Day Stock Price Change

Over the past seven days, Neurocrine Biosciences Inc. (NBIX) moved from $140.71 to $141.57, representing a gain of 0.61% ($0.86).

The stock traded between $139.61 and $146.92 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.

The average daily volume was 1.47 million shares, up versus the previous seven-day period, indicating higher trading activity.

NBIX 52-Week Price Position

Position in Range: 30.4%

52W Low$122.14

52W High$186.12

NBIX is currently trading at $141.57, placing it 30.4% of the way from its 52-week low of $122.14 to its 52-week high of $186.12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Neurocrine Biosciences Inc. (NBIX)?

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Neurocrine Biosciences Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	2500
Exchange	NASDAQ
Company Website	https://www.neurocrine.com

How to Buy Neurocrine Biosciences Inc. (NBIX) Stock on MEXC

Eligible investors can buy real shares of Neurocrine Biosciences Inc. (NBIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for NBIX and Place Your Order

Open the RealStocks trading page and search for NBIX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Neurocrine Biosciences Inc. (NBIX) stock price today?

Neurocrine Biosciences Inc. (NBIX) is currently trading at $ 141.57, down 0.61% ($0.87) from the previous close of $ 142.44. Intraday prices update in real time during regular trading hours.

2.Is NBIX stock going up or down today?

As of 2026-10-12 13:21:00, NBIX is trading at $ 141.57, down 0.61% ($0.87) from its previous close of $ 142.44. The stock has traded between $ 1.94 and $ 186.12 during today’s regular session. Past price movements do not guarantee future results.

3.What is NBIX pre-market price?

As of 2026-10-12 13:21:00, NBIX is trading at $ 141.57 in pre-market trading, down 0.61% ($0.87) from the previous close of $ 142.44. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is NBIX after-hours price?

As of 2026-10-12 13:21:00, NBIX is trading at $ 142.30 in after-hours trading, down 0.10% ($0.14) from the regular-session close of $ 142.44. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is NBIX stock trading now?

NBIX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does NBIX sit relative to its 52-week high and low?

Over the past 52 weeks, NBIX has traded between a low of $ 122.14 and a high of $ 186.12. At $ 141.57, the stock is positioned 30.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Neurocrine Biosciences Inc. in?

Neurocrine Biosciences Inc. (NBIX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Neurocrine Biosciences Inc.'s market capitalisation and where is it listed?

Neurocrine Biosciences Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 14.48B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is NBIX valued in terms of P/E ratio and EPS?

NBIX trades at a P/E ratio of 20.52, based on trailing-twelve-month EPS of $ 6.94. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Neurocrine Biosciences Inc. pay a dividend?

Neurocrine Biosciences Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.